Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2012, 5(6), 655-664; doi:10.3390/ph5060655
Review

The Potential Therapeutic Efficacy of Lactobacillus GG in Children with Food Allergies

1,2,* , 1
, 1
, 1
, 1
, 3
 and 1
Received: 16 May 2012; in revised form: 4 June 2012 / Accepted: 6 June 2012 / Published: 19 June 2012
(This article belongs to the Special Issue Probiotics and Prebiotics)
View Full-Text   |   Download PDF [570 KB, uploaded 19 June 2012]
Abstract: Food allergy (FA) continues to be a growing health concern for infants living in Western countries. The long-term prognosis for the majority of affected infants is good, with 80–90% naturally acquiring tolerance by the age of five years. However, recent studies suggest that the natural history of FA is changing, with an increasing persistence until later ages. The pathogenesis of FA as well as oral tolerance is complex and not completely known, although numerous studies implicate gut-associated immunity and enteric microflora, and it has been suggested that an altered composition of intestinal microflora results in an unbalanced local and systemic immune response to food allergens. In addition, there are qualitative and quantitative differences in the composition of gut microbiota between patients affected by FA and healthy infants. These findings prompted the concept that specific beneficial bacteria from the human intestinal microflora, designated probiotics, could restore intestinal homeostasis and prevent or alleviate allergy, at least in part by interacting with the intestinal immune cells.
Keywords: food allergy; probiotic; intestinal microflora; immune system; Lactobacillus GG; cow’s milk allergy; tolerance acquisition; atopic march; pediatrics; infants food allergy; probiotic; intestinal microflora; immune system; Lactobacillus GG; cow’s milk allergy; tolerance acquisition; atopic march; pediatrics; infants
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Berni Canani, R.; Di Costanzo, M.; Pezzella, V.; Cosenza, L.; Granata, V.; Terrin, G.; Nocerino, R. The Potential Therapeutic Efficacy of Lactobacillus GG in Children with Food Allergies. Pharmaceuticals 2012, 5, 655-664.

AMA Style

Berni Canani R, Di Costanzo M, Pezzella V, Cosenza L, Granata V, Terrin G, Nocerino R. The Potential Therapeutic Efficacy of Lactobacillus GG in Children with Food Allergies. Pharmaceuticals. 2012; 5(6):655-664.

Chicago/Turabian Style

Berni Canani, Roberto; Di Costanzo, Margherita; Pezzella, Vincenza; Cosenza, Linda; Granata, Viviana; Terrin, Gianluca; Nocerino, Rita. 2012. "The Potential Therapeutic Efficacy of Lactobacillus GG in Children with Food Allergies." Pharmaceuticals 5, no. 6: 655-664.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert